I guess I didn’t research the title “opinyon” but it
I guess I didn’t research the title “opinyon” but it is still the opinion of one person with no proof.
I have a 5 figure amount of stock and want only for Leronlimab to succeed. The proof of succeeding is in the trials. We show great potential and life saving ability but have not shown 30% efficacy in our primary end point needed for EUA. That’s is a fact. We can whine all day about wanting an approval from the FDA but they just look at us and say... if only you hit the 30% we would bend over backwards giving you the EUA. We can beg for an EUA and say others got approval when they didn’t show the 30% efficacy why can’t we have approval?
These are all valid complaints and heaven knows the pandemic needs us. But the fact is we didn’t hit our numbers YET. That’s a big YET to me. I believe we can and will hit our proper efficacy and strength in another trial. It would be a gift for the FDA to give us a EUA on results that we have shown so far. Believe me when I say I want that gift and I don’t want to wait for another trial. I don’t... but life’s little mysteries don’t always happen the way I want them too.
If we have to wait we have to wait. It’s out of our control is my point. It’s not big Pharma pushing us down. We have to earn our place in statistical evidence and we just have quite got there YET. We will is my opinion. I do hope that internationally we show the world that Leronlimab works and will be approved everywhere. Our FDA might be the last one to approve but they have the right to make us show proof. Hence... no conspiracy...
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Integrated Power Services to Feature at RE+ Integrated Power Services (IPS) stands out as a pioneer in the realm of electrical, mechanical, and power management systems. At the upcoming RE+ event, set to take place in September in Las Vegas, IPS will present its cutting-edge solar infrastructure and Battery Energy Storage Systems (BESS) solutions to an audience eager to...
Continue Reading
Recent Transactions Involving Octopus Apollo VCT PLC Directors Octopus Apollo VCT PLC has recently disclosed important transactions involving its directors and persons closely associated with them. Such notifications are crucial as they provide transparency about managerial activities within the company, helping investors stay informed about potential changes in ownership...
Continue Reading
Let's cut to the chase: Crown Laboratories is flexing hard with PanOxyl's recent haul at the Allure 2024 Best of Beauty Awards. Not just a couple of shiny trinkets; we're talking about their Acne Foaming Wash and Overnight Spot Patches being recognized among the crème de la crème in the beauty biz. These aren’t just awards; they're a litmus test for what works in acne...
Continue Reading
Celebrating Global Impact: Academy for Creating Enterprise Grows In an impressive recognition of 25 years of dedicated service, the Academy for Creating Enterprise has joyfully marked the launch of its 1,000th chapter, coupled with the introduction of a dynamic sponsorship program aimed at enhancing growth and support for emerging entrepreneurs. This significant milestone...
Continue Reading
Chipotle Mexican Grill's Stock Price Decline Recently, Chipotle Mexican Grill, Inc.'s stock saw a significant drop of 7.5%, sparking concerns among investors. This decline follows troubling allegations related to the quality of food served at their restaurants, raising questions about accountability and management practices within the company. The Class Action Lawsuit...
Continue Reading